Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. AcouSort AB's Revenue for the
three
months ended in Mar. 2026 was kr2.15 Mil. AcouSort AB's average Accounts Receivable for the
three
months ended in Mar. 2026 was kr0.21 Mil.
Hence, AcouSort AB's Receivables Turnover for the
three
months ended in Mar. 2026 was 10.37.
AcouSort AB (OSTO:ACOU) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
AcouSort AB Receivables Turnover Related Terms
AcouSort AB Receivables Turnover Historical Data
* Premium members only.
The historical data trend for AcouSort AB's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ACOU vs VRTX, REGN, ALNY: Receivables Turnover Comparison
For the Biotechnology subindustry, AcouSort AB's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AcouSort AB Receivables Turnover vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, AcouSort AB's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where AcouSort AB's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AcouSort AB (OSTO:ACOU) has a Receivables Turnover of 10.37 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on AcouSort AB and its competitors. According to the industry distribution chart, AcouSort AB ranks #37 out of 841 companies in the Biotechnology industry, placing it in the top 4.4%.
Is AcouSort AB's Receivables Turnover too high?
AcouSort AB's current Receivables Turnover is 10.37. The Biotechnology industry median Receivables Turnover is 5.29. AcouSort AB's value of 10.37 is 96% above this industry median. Based on the distribution chart, AcouSort AB ranks #37 out of 841 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, AcouSort AB has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AcouSort AB's Receivables Turnover compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, AcouSort AB ranks #37 out of 841 companies for Receivables Turnover. This places AcouSort AB in the top 4% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.29. AcouSort AB's value of 10.37 is 96% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.29, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AcouSort AB's current Receivables Turnover of 10.37 is 96% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on AcouSort AB and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AcouSort AB's current Receivables Turnover is 10.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AcouSort AB stock overvalued right now?
Based on GuruFocus' analysis, AcouSort AB (OSTO:ACOU) is currently considered Possible Value Trap. The stock's GF Value™ is kr9.18, compared to a current price of kr3.86 — trading 58% below its estimated fair value. The current Receivables Turnover is 10.37 and 96% above the Biotechnology industry median of 5.29. AcouSort AB's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For AcouSort AB (OSTO:ACOU), the current Receivables Turnover is 10.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AcouSort AB (OSTO:ACOU) Overvalued in 2026?
Based on GuruFocus' analysis, AcouSort AB stock appears to be undervalued.
The current stock price of kr3.86 is trading 58% below its estimated GF Value™ of kr9.18.
GuruFocus considers AcouSort AB to be Possible Value Trap.
Key valuation signals for OSTO:ACOU:
Receivables Turnover: 10.37
GF Value™: kr9.18 vs. price of kr3.86 (58% below fair value)
Industry Position: 96% above the Biotechnology median (#37 of 841)
No single metric tells the full story. See the OSTO:ACOU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AcouSort AB is a company that specializes in products and solutions for the automated preparation of biological samples for researchers and life science companies. Its technology is based on using ultrasound to isolate, separate, or trap microscopic particles such as blood cells, bacteria, or extracellular vesicles in microfluidic channels. The company's products includes AcouTrap, AcouWash, and AcouPlasma.
50GF Score
Get the complete analysis for OSTO:ACOU
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ACOU has been successfully added to your 
